World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 3 August 2015
Main ID:  NCT02495051
Date of registration: 22/06/2015
Prospective Registration: No
Primary sponsor: University Hospital, Lille
Public title: Esophageal Atresia: Metaplasia, Barrett Oesophagix
Scientific title: Prevalence of Barrett's Esophagus in Adolescents and Young Adults With Esophageal Atresia
Date of first enrolment: February 2010
Target sample size: 120
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02495051
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Belgium Canada France Luxembourg
Contacts
Name:     Frédéric Gottrand, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Lille
Key inclusion & exclusion criteria

Inclusion Criteria:

- Medical history of esophageal atresia (all types, Ladd's classification)

Exclusion Criteria:

- No medical history of esophageal atresia

- Non acceptance to participate from the patient and/or his parents

- esophageal atresia treated with esophageal replacement (e.g., coloplasty, gastric
transposition)



Age minimum: 15 Years
Age maximum: 19 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Esophagus, Barrett
Gastroesophageal Reflux
Intervention(s)
Procedure: esophageal biopsies
Primary Outcome(s)
presence of gastric and / or intestinal metaplasia diagnosed at histology [Time Frame: during 2 hours of the endoscopy exam]
Secondary Outcome(s)
evaluation of actual symptoms and treatment of gastroesophageal reflux disease [Time Frame: during the single visit scheduled, the day of endoscopy. This periode is corresponding at a day hospitalization (less than 12 hours in the day)]
evaluation of actual other symptoms (respiratory, dysphagia) [Time Frame: during the single visit scheduled, the day of endoscopy. This periode is corresponding at a day hospitalization (less than 12 hours in the day)]
presence of esophagitis or anomalies at the anastomotic stage diagnosed at histology [Time Frame: during 2 hours of the endoscopy exam]
evaluation of the nutritional status [Time Frame: during the single visit scheduled, the day of endoscopy. This periode is corresponding at a day hospitalization (less than 12 hours in the day)]
Secondary ID(s)
2009/cic
DR-2011-057 / A 910270
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history